Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lilian Larsson"'
Autor:
Osman Ahmed, Karin Littmann, Ulf Gustafsson, Camilla Pramfalk, Katariina Öörni, Lilian Larsson, Mirko E. Minniti, Staffan Sahlin, German Camejo, Paolo Parini, Mats Eriksson
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 24 (2018)
Background In randomized trials (SHARP [Study of Heart and Renal Protection], IMPROVE‐IT [Improved Reduction of Outcomes: Vytorin Efficacy International Trial]), combination of statin and ezetimibe resulted in additional reduction of cardiovascular
Externí odkaz:
https://doaj.org/article/288d0fb803c24c84b43d61aa5ebe9657
Autor:
Matteo Pedrelli, Padideh Davoodpour, Chiara Degirolamo, Monica Gomaraschi, Mark Graham, Alice Ossoli, Lilian Larsson, Laura Calabresi, Jan-Åke Gustafsson, Knut R Steffensen, Mats Eriksson, Paolo Parini
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e93552 (2014)
OBJECTIVES: ACAT2 is the exclusive cholesterol-esterifying enzyme in hepatocytes and enterocytes. Hepatic ABCA1 transfers unesterified cholesterol (UC) to apoAI, thus generating HDL. By changing the hepatic UC pool available for ABCA1, ACAT2 may affe
Externí odkaz:
https://doaj.org/article/84f8dce4f8ea4df6a4d1616d2b236234
Autor:
Lisa-Mari Mörk, Stefan Rehnmark, Padideh Davoodpour, Giuseppe Danilo Norata, Lilian Larsson, Michael-Robin Witt, Johan Malm, Paolo Parini
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e78534 (2013)
BACKGROUND: Thyroid hormones (TH) regulate cholesterol metabolism but their use as lipid-lowering drugs is restricted due to negative cardiac effects. TH mimetic compounds modulating TH receptor β (THRβ) have been designed as potential drugs, reduc
Externí odkaz:
https://doaj.org/article/f4e0c781ac524f8d98d68581c14675a0
Transforming growth factor β induced factor homeobox (TGIF) 1 and 2 are two transcriptional repressors. Although TGIF1 has been found to be involved in lipid metabolism, no studies have yet investigated the role of TGIF2 in hepatic lipid metabolism.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::035b69c5a4a8f4fe0fc43ce896fce8e6
https://doi.org/10.1016/j.bbalip.2019.02.009
https://doi.org/10.1016/j.bbalip.2019.02.009
Autor:
Mirko E. Minniti, Mats Eriksson, Camilla Pramfalk, Ulf Gustafsson, Katariina Öörni, Germán Camejo, Staffan Sahlin, Lilian Larsson, Karin Littmann, Paolo Parini, Osman Ahmed
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background In randomized trials (SHARP [Study of Heart and Renal Protection], IMPROVE ‐IT [Improved Reduction of Outcomes: Vytorin Efficacy International Trial]), combination of statin and ezetimibe resulted in additional reduction of cardiovascula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ce52190e38cfbdf3b13358aec7361ae
https://doi.org/10.1161/jaha.118.009876
https://doi.org/10.1161/jaha.118.009876
Autor:
Camilla Pramfalk, Mats Eriksson, Lilian Larsson, Osman Ahmed, Tiffany A. Melhuish, David Wotton, Paolo Parini
Publikováno v:
Atherosclerosis. 275
Background and aims Transforming growth factor β induced factor homeobox 1 (TGIF1) is a transcriptional repressor that limits the response to transforming growth factor s signaling and also represses transcription independent of this pathway. Recent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14748c958c652bd797783f242ffae05c
https://pubmed.ncbi.nlm.nih.gov/29980051
https://pubmed.ncbi.nlm.nih.gov/29980051
Autor:
Cristina S. J. Rocha, Oscar P. B. Wiklander, Pedro Moreno, C. I. Edvard Smith, Lilian Larsson, Karin E. Lundin, Paolo Parini
Publikováno v:
Journal of Molecular and Cellular Cardiology. 82:186-193
Hypercholesterolemia is a medical condition often characterized by high levels of low-density lipoprotein cholesterol (LDL-C) in the blood. Despite the available therapies, not all patients show sufficient responses, especially those with very high l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90796cb84e46de90530f175400d55deb
Autor:
Paolo Parini, E. Callaghan, Helen Zemack, Lilian Larsson, T. Takahashi, Ewa Ellis, Greg Nowak, Bo-Göran Ericzon, Carl Jorns
Publikováno v:
Transplantation Proceedings. 45:1780-1786
Introduction Hepatocyte transplantation, a promising treatment for patients with acute hepatic failure or metabolic liver diseases, requires improvement in engraftment as well as long-term function of the liver cells. We established a hepatocyte tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbcf4a50c6b9bc003b4f461e8ce35273
https://doi.org/10.1016/j.transproceed.2013.01.032
https://doi.org/10.1016/j.transproceed.2013.01.032
Autor:
Lilian Larsson, Germán Camejo, Paolo Parini, Camilla Pramfalk, Ulf Gustafsson, Karin Littmann, Mats Eriksson, Osman Ahmed, Katariina Öörni, Staffan Sahlin
Publikováno v:
Atherosclerosis. 275:e234
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd82af5c11ee96d59895ab1493de0f18
https://doi.org/10.1016/j.atherosclerosis.2018.06.739
https://doi.org/10.1016/j.atherosclerosis.2018.06.739
Autor:
R.G. Denis, Osman Ahmed, Paolo Parini, Knut R. Steffensen, Lilian Larsson, Serge Luquet, M. Tellez, Camilla Pramfalk, Anne-Sophie Delbes, Lise Lotte Vedin, J. Härdfeldt, Mats Eriksson, Matteo Pedrelli
Publikováno v:
Atherosclerosis. 275:e25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1ab8209a5d95deba8820c618dfd2790
https://doi.org/10.1016/j.atherosclerosis.2018.06.060
https://doi.org/10.1016/j.atherosclerosis.2018.06.060